Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores

Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores

PromarkerD is a biomarker-based blood test that predicts kidney function decline in people with type 2 diabetes (T2D) who may otherwise be missed by current standard of care tests. This study examined the association between canagliflozin and change in PromarkerD score (Δ score) over a three-year pe...

Full description

Bibliographic Details
Main Authors: Kirsten E. Peters, Scott D. Bringans, Ronan S. O’Neill, Tasha S. C. Lumbantobing, James K. C. Lui, Timothy M. E. Davis, Michael K. Hansen, Richard J. Lipscombe
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Clinical Medicine
Subjects:
type 2 diabetes
diabetic nephropathy
kidney decline
chronic kidney disease
biomarkers
risk prediction
Online Access:https://www.mdpi.com/2077-0383/12/9/3247

Internet

https://www.mdpi.com/2077-0383/12/9/3247

Similar Items